Alan Ashworth took a cancer drug from Petri dish to patients in near record speed. Daniel Cressey meets a biologist who is evangelical about translational research.
This is a preview of subscription content, log in via an institution to check access.
References
Iglehart, J. D. & Silver, D. P. N. Engl. J. Med. 361, 189-191 (2009).
Wooster, R. et al. Science 265, 2088-2090 (1994).
Wooster, R. et al. Nature 378, 789-792 (1995).
Connor, F. et al. Nature Genet. 17, 423-430 (1997).
Farmer, H. et al. Nature 434, 917-921 (2005).
Bryant, H. E. et al. Nature 434, 913-917 (2005).
Fong, P. C. et al. N. Engl. J. Med. 361, 123-134 (2009).
Tutt, A. et al. J. Clin. Oncol. (Meeting Abstracts) 27, CRA501 (2009).
Mendes-Pereira, A. M. et al. EMBO Mol. Med. 1, 315-322 (2009).
Edwards, S. L. et al. Nature 451, 1111-1115 (2008).
Sakai, W. et al. Nature 451, 1116-1120 (2008).
Additional information
Daniel Cressey is a reporter based in Nature's London office.
Related links
Related links
Related links in Nature Research
Translational research news special
Related external links
Rights and permissions
About this article
Cite this article
Cressey, D. Translational research: Talking up translation. Nature 463, 422–423 (2010). https://doi.org/10.1038/463422a
Published:
Issue Date:
DOI: https://doi.org/10.1038/463422a
- Springer Nature Limited
This article is cited by
-
The hope of progress
BMC Biology (2010)